Detalles de la búsqueda
1.
A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma.
Br J Haematol;
178(3): 434-441, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28440559
2.
Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.
Br J Haematol;
178(2): 250-256, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28419413
3.
Canada needs a funding institute focused on environments, health, and societal well-being research.
Can J Public Health;
114(4): 525-529, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37410366
4.
Differences in Quality of Life Between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma.
Clin Lymphoma Myeloma Leuk;
16(4): 182-190.e1, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26875824
5.
Effect of bendamustine in combination with rituximab on QT interval duration in patients with advanced de novo indolent non-Hodgkin or mantle cell lymphoma.
Cancer Chemother Pharmacol;
76(1): 211-6, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26006703
6.
Bendamustine produces durable responses with an acceptable safety profile in patients with rituximab-refractory indolent non-Hodgkin lymphoma.
Clin Lymphoma Myeloma Leuk;
10(6): 452-7, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21189660
7.
Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: results from a Multicenter Study.
Cancer;
116(1): 106-14, 2010 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19890959
8.
Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.
J Clin Oncol;
26(27): 4473-9, 2008 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18626004
9.
Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study.
J Clin Oncol;
26(2): 204-10, 2008 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18182663
10.
Sequential flavopiridol, mitoxantrone and cytosine arabinoside for newly diagnosed poor risk acute myeloid leukemia. What to do next?
Leuk Res;
34(7): 856-7, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20378170
Resultados
1 -
10
de 10
1
Próxima >
>>